cis-Sabinene hydrate is a monoterpene alcohol associated with marjoram-like, thyme-like, and savory aromatic profiles, and it has a stronger direct literature footprint than many minor terpenes because both occurrence and antimicrobial work are publicly accessible. The evidence is still mostly analytical or preclinical, not clinical, but it is solid enough to support careful discussion of aroma identity, chemotype relevance, biosynthetic stereochemistry, and in-vitro antimicrobial findings. AromaForge should present it as a characterful monoterpene alcohol with real preclinical activity signals and equally clear evidence limits.
Chemical identity and composition
PubChem and The Good Scents Company both support sabinene hydrate as C10H18O, but public registries split the constituent across generic and stereospecific records. The archive already links the cis constituent to Sweet Marjoram at 15.0%, Marjoram at 3.8%, and Summer Savory at 0.87%, which fits its role as a recognizable chemotype marker in some Lamiaceae oils.
Aroma and practical use
- Use the recorded minty, eucalyptus-like, green, terpenic, cooling, spicy descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
direct antimicrobial screening
A 2024 full-text study on sabinene hydrate reported that Gram-positive bacteria were the most susceptible tested organisms, with MIC values of 0.0312 mg/mL for Bacillus subtilis and 0.0625 mg/mL for Staphylococcus aureus in the disc-volatilization method; the tested commercial sabinene hydrate was mainly trans-isomer, so transfer to the pure cis isomer is suggestive rather than definitive.
Measured: growth inhibition and minimum inhibitory concentrations
This experimental finding does not establish benefit, dose or safety in people using this blend.
new cis chemotype detection
A Journal of Essential Oil Research paper reported a new cis-sabinene hydrate chemotype in wild large thyme, supporting the constituent's value as a chemotaxonomic and aroma-profile marker rather than just a trace analyte.
Measured: detection of a cis-sabinene-hydrate-rich chemotype
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot assessed
Not assessed in the available record.
Penetration enhancementNot assessed
Not assessed in the available record.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedThe Good Scents page reviewed in this pass lists sabinene hydrate as a flavor and fragrance agent and shows a maximum skin level for fine fragrances of 0.0200% alongside a recommendation of up to 0.5000% in fragrance concentrate.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
The strongest public activity study located here used commercially available sabinene hydrate composed mainly of the trans isomer, so cis-specific safety and efficacy conclusions should remain conservative.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No constituent-specific human clinical safety paper for isolated cis-sabinene hydrate was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
stereoselective metal dependent terpene cyclization
The sabinene hydrate literature describes formation through terpene-synthase-mediated monoterpene cyclization from prenyl diphosphate precursors, with metal ions such as Mn2+ or Mg2+ involved and distinct enzymes linked to different stereoisomers.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- The most direct antimicrobial paper tested sabinene hydrate material composed mainly of the trans isomer, so cis-specific transfer remains imperfect.
- Public registry sources distribute sabinene hydrate identity across generic and stereospecific records, which can create CAS ambiguity.
- No human clinical literature for isolated cis-sabinene hydrate was verified in this pass.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.